A modern, holistic, end-to-end regulatory information management (RIM) system can help to greatly improve the efficiency of regulatory data, content and process management, deliver substantial cost savings, and enhance the quality of final output. Without a modern...
Tag:
Visit us at the 2nd Pharmaceutical Regulatory Affairs Summit
We will exhibit at the forthcoming 2nd Pharmaceutical Regulatory Affairs Summit, which will be held in Vienna on 26-27 October. The Summit is designed to explore the most interesting regulatory topics of 2022, including regulatory status during COVID-19, decentralised...
Visit us at TOPRA 2022
We will exhibit at the forthcoming TOPRA Annual Symposium in Vienna on 17-19 October. The Symposium, which encompasses human pharmaceuticals, medical devices/IVDs and veterinary medicines, brings together key regulatory professionals from big pharma, small and...
5 Major Efficiency Boosts for Your Regulatory Operations
This webinar will focus on 5 capabilities that a modern holistic RIM system can provide to greatly improve efficiency of regulatory data, content and process management and consequently incur substantial cost savings while retaining same or even increase the quality of final outputs.
Visit us at RAPS Convergence 2022
RAPS Convergence 2022 returns in-person, bringing industry professionals and regulators together to co-create, problem-solve and discuss global and local challenges facing professionals in the regulatory life sciences community. It will be thrilling to return to a...
Achieving effective, repeatable, risk-based pharma change control
Most life sciences products continue to evolve long after approved formulations have entered the market, and all of these changes must be carefully tracked, managed and reported to maintain registrations, manufacturing transparency and patient safety.
Cloud control: maintaining compliance as regulated apps move off premise
As pharmaceutical companies become more confident and ambitious in their use of the cloud to host, run and source applications, more recently extending the model to regulated applications, important considerations arise – particularly around associated systems validation and data governance.
Dynamic digital labels: from local pilot to regional reality
The potential of truly digital, data-driven product labeling in life sciences is huge, allowing companies to tailor and update their information more readily, unencumbered by space restrictions or print/production line deadlines. But what will it take for today’s discrete, local pilot projects to evolve into something more permanent and transformational for patients and healthcare professionals?